Two cases of medullary thyroid carcinoma

Annals of the Academy of Medicine Singapore

Volumn 30, Issue 6, 2001, Pages 646-650

  Jong, Michelle ^a   Sundram, F X ^b  

^a TAN TOCK SENG HOSPITAL   (Singapore)

^b NONE

Author keywords

Carcinoembryonic antigen; Codon 638; Multiple endocrine neoplasia 2A; RET proto oncogene mutations; Tc 99m (V) DMSA imaging; Tc 99m sestamibi

Indexed keywords

ADULT; CASE REPORT; GENETIC SCREENING; GENETICS; HUMAN; MALE; MEDULLARY CARCINOMA; MULTIMODALITY CANCER THERAPY; MUTATION; REVIEW; SIPPLE SYNDROME; THYROID TUMOR;

ADULT; CARCINOMA, MEDULLARY; CASE REPORT; COMBINED MODALITY THERAPY; GENETIC SCREENING; GERM-LINE MUTATION; HUMAN; MALE; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; THYROID NEOPLASMS;

EID: 0035515520     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Gilliland F D, Hunt W C, Morris D M, Key C R. Prognostic factors for thyroid carcinoma: a population based study of 15,698 cases from surveillance. Epidemiology and end results surveillance program 1973-1991. Cancer 1997; 79:564-73.
2. Hundahl S A, Fleming A M, Menck H R. A national cancer database report on 53,856 cases of thyroid carcinoma treated in the US 1985-1995. Cancer 1998; 83:2638-48.
3. Marsh D J, Leoroyd D L, Robinson B G. Medullary thyroid carcinoma; recent advances and management update. Thyroid 1995; 5:407-20.
4. Mendelsohn G, Wells S A Jr, Baylin S B. Relationship of tissue carcinoembryonic antigen and calcitonin to tumour virulence in medullary thyroid carcinoma. An immunohistochemical study in early, localized, and virulent disseminated stages of the disease. Cancer 1984; 54:657-62.
5. Randolph G W, Maniar D. Medullary thyroid carcinoma of the thyroid. Cancer Control 2000; 7:253-61.
6. Bi L, Lu B. Advances in the diagnosis and management of thyroid neoplasms. Curr Opin Oncol 2000; 12:54-9.
7. Kebebew E, Ituarte P H G, Siperstein A E, Duh Q Y, Orlo H C. Medullary thyroid carcinoma. Clinical characteristics, treatment, prognostic factors and a comparison of clinical staging. Cancer 2000; 88:1139-48.
8. Cohen R, Campos J M, Salaun C, Heshmati H M, Kraimps J L, Proye C, et al. Preoperative calcitonin levels are predictive of tumour size and postoperative normalization in medullary thyroid carcinoma. J Clin Endocrinol Metab 2000; 85:919-22.
9. Fleming J B, Lee J E, Bouvet M, Schultz, P N, Sherman S I, Sellin R V, et al. Surgical strategy for the treatment of medullary thyroid carcinoma. Ann Surg 1999; 230:697-707.
10. Burh H J, Kallinowski F, Raue F, Frank-Raue K, Herfarth C. Microsurgical neck dissection for metastasizing medullary thyroid carcinoma. Eur J Surg Oncol 1995; 21:195-7.
11. Dralle H, Damm I, Scheumann G F, Kotzerke J, Kupsch E, Geerlings H, et al. Compartment-orientated microdissection of regional lymph nodes in medullary thyroid carcinoma. Surg Today 1994; 24:112-21.
12. de Labriolle-Vaylet C, Cattan P, Sarfati E, Wioland M, Billotey C, Brocheriou C, et al. Successful surgical removal of occult metastases of medullary thyroid carcinoma recurrences with the help of immunoscintigraphy and radioimmunoguided surgery. Clin Cancer Res 2000; 6:363-71.
13. Shikare S, Bashir K, Menon P S, Bapat R D, Tilve G H. Detection of medullary thyroid carcinoma with liver metastases using 99m Tc DMSA (V) scintigraphy. J Postgrad Med 1995; 41:12-3.
14. Adelet I, Kocak M, Oguz H, Alagol F Cantez S. Determination of medullary thyroid carcinoma metastases by 201TI, 99Tcm (V) DMSA, 99T-MIBI and 99T-tetrafosmin. Nucl Med Commun 1999; 20:353-9.
15. Ugur O, Kostakglu L, Guler N, Caner B, Uysal U, Elahi N, et al. Comparison of 99m Tc(V)-DMSA, 201TI and 99m-Tc-MIBI imaging in the follow-up of patients with medullary thyroid carcinoma. Eur J Nucl Med 1996; 23:1367-71.
16. Yen T C, King K L, Yang A H, Liu R S, Yeh S H. Comparative radionuclide imaging of metastatic insular carcinoma of the thyroid; value of Tc-99m-(V) DMSA. J Nucl Med 1996; 37:78-80.
17. Learoyd D L, Delbridge L W, Robinson B G. Multiple endocrine neoplasia. Aust N Z J Med 2000; 30:675-82.
18. Wohllk N, Cote G J, Bugalho M M. Relevence of RET protooncogene mutations in sporadic medullary thyroid carcinoma. J Clin Endocrinol Metab 1996; 81:3740-5.
19. Eng C, Clayton D, Schuffenecker I, Lenoir G, Cote G, Gagel R F, et al. The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. JAMA 1996; 276:1575-9.
20. Lips C J, Landsvater R M, Hoppener J W, Geerdink R A, Blijham G, van Veen J M, et al. Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A. N Engl J Med 1994; 331:828-35
21. Marsh D J, McDowall D, Hyland V J, Andrew S D, Schnitzler M, Gaskin E L, et al. The identification of false positive responses to the pentagastrin stimulation test in RET mutation negative members of MEN 2A families. Clin Endocrinol 1996; 44:213-220.
22. Gill J R, Reyes-Mugica M, Iyengar S, Kidd K K, Touloukian R J, Smith C, et al. Early presentation of metastatic medullary carcinoma in multiple endocrine neoplasia, type IIA: implications for therapy. J Pediatr 1996; 129:459-64.
23. van Heurn L W, Schaap C, Sie G, Haagen A A, Gerver W J, Freling G, et al Predictive DNA testing for multiple endocrine neoplasia 2: a therapeutic challenge of prophylactic thyroidectomy in very young children. J Pediatr Surg 1999; 34:568-71.
24. Hinze R, Holzhausen H J, Gimm O, Dralle H, Rath F W. Primary hereditary medullary thyroid carcinoma. Virchows Arch 1999; 433:203-8.
25. Ceccherini I, Hofstra R M, Luo Y, Stulp R P, Barone V, Stelwagen T, et al. DNA polymorphisms and conditions for SSCP analysis of the 20 exons of the ret proto-oncogene. Oncogene 1994; 9: 3025-9.
26. Huang C N, Wu S L, Chang T C, Huang S H, Chang T J. RET protooncogene mutations in patients with apparently sporadic medullary thyroid carcinoma. J Formos Med Assoc 1998; 97:541-6.
27. Krueger J E, Maitra A, Albores-Saavedra J. Inherited medullary microcarcinoma of the thyroid. A study of 11 cases. Am J Surg Pathol 2000; 24:853-8.
28. Girelli M E, Bellastella A, Colantuoni V. Germline and somatic mutations of the RET proto-oncogene in apparently sporadic medullary thyroid carcinomas. Mol Cell Endocrinol 1998; 135: 51-7.
29. Girelli M E, Nacamulli D, Pelizzo M R, De Vido D, Mian C, Piccolo M, et al. Medullary thyroid carcinoma: clinical features and long-term follow-up of 78 patients treated between 1969-1986. Thyroid 1998; 8:517-23.
30. Bergholm U, Berstom R, Ekbom A. Long term follow-up of patients with medullary thyroid carcinoma of the thyroid. Cancer 1997; 79:132-8.